This webinar offers a spotlight preview of the clinical topics that will be explored in depth at our upcoming I/DD & Behavioral Health Symposium. Designed as a high-level overview, the session highlights key medication and behavioral health challenges commonly seen in individuals with intellectual and developmental disabilities.
Participants will gain an early look at top medication issues in I/DD care, the use of SSRIs and SNRIs in treating depression, psychiatric disorders in individuals with co-occurring seizure conditions, and selected CNS-related comorbidities in epilepsy that influence antiseizure medication selection. This session is intended to provide context, spark discussion, and prepare attendees for the deeper clinical learning and practical application offered at the full symposium.
Presenter
Nanette Wrobel, RPh, Director of Corporate Education and Business Development, Tarrytown Expocare
Stay Informed on the Latest Research & Analysis from ANCOR
